期刊文献+

维吾尔族肥胖伴胰岛素抵抗患者内脂素的表达变化及意义 被引量:4

Changes and significance of serum visfatin levels in Uygur obese patients with insulin resistance
下载PDF
导出
摘要 目的探讨维吾尔族肥胖(OB)伴胰岛素抵抗(IR)患者血清内脂素的变化及意义。方法根据胰岛素抵抗诊断标准(胰岛素抵抗指数≥2.8),将患者分为肥胖伴胰岛素抵抗组(OB伴IR组)31例,肥胖无胰岛素抵抗组(OB无IR组)26例,另选14例健康体检者为正常对照组。半定量RT-PCR方法检查研究对象网膜和皮下脂肪组织内脂素mRNA的表达水平。对所有受试者采用稳态模式评估法(HOMA)评价胰岛素抵抗(IR),采用ELISA法测定血清内脂素水平,同时进行临床生化参数的检测。结果(1)OB伴IR组血清内脂素水平高于OB无IR组,差异有统计学意义(P<0.05)。(2)血清内脂素与体质量、甘油三酯(TG)呈正相关,与高密度脂蛋白-胆固醇(HDL-C)呈负相关。(3)3组网膜与皮下脂肪组织内脂素mRNA表达水平差异无统计学意义。结论血清内脂素水平的升高可能与维吾尔族肥胖患者的胰岛素抵抗有关。 Objective To investigate the changes and significance of serum visfatin levels in obese patients with insulin resistance. Methods Patients with insulin resistance index ≥2.8 was diagnosed as insulin re-sistance. A total of 71 cases were divided into obese with insulin resistance group (OB with IR) (n=31), obesity without resistance group (OB without IR) (n=26) and control group (n=14). The visfatin mR NA expressions in abdominal omental and subcutaneous adipose tissues by semi-quantitative were investi-gated by reverse transcription polymerase chain reaction (RT-PCR). All subjects were evaluated by the homeostasis model assessment (HOMA) insulin resistance (IR), and the ELISA method was used for the determination of serum visfatin levels,while the general examination of blood sugar, lipids and other bio- chemical tests. Results (1) The levels of serum visfatin were significantly increased in OB with IR group than OB without IR group (P〈 d0.05). (2) The level of serum visfatin was positively correlated with weight and triglyeride (TG), was negatively correlated with high density lipoprotein cholesterol (HDL-C). (3) There were no significant differences in the abdominal omental and subcutaneous adipose tissue visfatin mRNA ciated with the expression between the three groups. Conclusion The level of serum visfatin may be asso-insulin resistance.
出处 《新疆医科大学学报》 CAS 2012年第5期565-569,共5页 Journal of Xinjiang Medical University
基金 国家自然科学基金项目(30960363)
关键词 内脂素 肥胖 胰岛素抵抗 visfatin obesity insulin resistance
  • 相关文献

参考文献10

  • 1Wang J, Brymora J,George J. Roles of adipokines in liver inju ry and fibrosis[J]. J Expert Rev Gastroenterol Hepatol,2008, 2(1):47- 57.
  • 2Fukulara A, Matsuda M. Visfatin:a protein secreted by visceral fat that mimics the effect of insulin[J]. J Science, 2005,307 (5708):426- 430.
  • 3田忠,李溪源,李异玲,刘金钢.肥胖及非酒精性脂肪性肝病患者血清内脂素的变化及意义[J].中国医科大学学报,2011,40(4):337-339. 被引量:11
  • 4Moschen AR, Kaser A, Enrich B,et al. Visfatin, an adipocy- tokine with proinflammatory and immunomodulating properties [J]. J Inmunol, 2007,178(3) : 1748-1758.
  • 5Berndt J, Kloting N, Kralisch S, et al. Plasma visfatin concen- trations and fat depot-specific mRNA expression in humans[J]. J Diabetes, 2005,54(10) : 2911-2916.
  • 6Sethi JK,Vidal-Puig A. Visfatin: the missing link between in- tra-abdominal obesity and diadetes[J]. J Tre nds Mol Med, 2005,11 (8) : 344-347.
  • 7Chen MP, Chung MF, Chang DM, et al. Elevated plasma level of visfatin/pre-Bcell colony" enhancing factor in patients with type 2 diabetes mellitus[J]. J Clin Endoerinol Metab, 2006,91 (1) :295-299.
  • 8Sandeep S, Velmurugan K, Deepa R,et al. Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians[J]. Metabolism,2007 ,56(4) :565-570.
  • 9鞠长年,薛江州,吴如雷,卢国群.血清内脂素与肥胖和2型糖尿病的关系[J].山东医药,2010,50(37):30-31. 被引量:1
  • 10Chu CH, Lee JK, Wang MC, et al. Change of visfatin,C-re active protein concentrations, and insulin sensitivity in pa tients with hyperthyroidism[J]. J Metabolism, 2008,57 (10) :1380 -1383.

二级参考文献15

  • 1杨媚,杨刚毅,李伶,李清明,阮华玲,阳皓,李钶,孙勤,唐毅,Gunther Boden.不同糖耐量个体血浆内脂素水平的变化[J].中华内分泌代谢杂志,2006,22(3):245-247. 被引量:76
  • 2刘蓉,朱剑,王茜,沈备,刘翠萍,徐宽枫,茅晓东,刘超.不同糖耐量人群及糖尿病患者血浆内脂素与血糖及胰岛功能的关系研究[J].中国实用内科杂志,2007,27(16):1278-1281. 被引量:89
  • 3Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insuli[J].Science,2005,307(5708):426-430.
  • 4Sandeep S,Ve1murugan K,Deepa R,et al.Serum visfatin in relation to visceral fat obesity,and type 2 diabetes mellitus in asian indians[J].Metabolism,2007,56(16):565-570.
  • 5Chen MP,Chung FM,Chang DM,et al.Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus[J].J Clin Endeerlnol Metab,2006,91(21):295-299.
  • 6Sevastianos VA, Hadziyannis SJ. Nonalcoholic fatty liver disease: from cliuieal recognition to treatment [J]. Expert Rev Gastroenterol Hepatol, 2008,2( 1 ) : 59-79.
  • 7中华医学会肝病分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南.中华肝病杂志,2006,1(14):66-68.
  • 8Wang J, Brymora J, George J. Roles of adipokines in liver injury and fibrosis[J 1- Expert Rev Gastroenterol Hepatol, 2008,2( 1 ) :47-57.
  • 9Rho YH,Chung CP,Solus JF,et al. Adipocytokines,insulin resis- tanee,and coronary atherosclerosis in rheumatoid arthritis [J]. Arthritis Rheum, 2010,62(5 ) : 1259-1264.
  • 10Moschen AR,Kaser A,Enrich B,et al. Visfatin,an adipocytokine with proinflavnmatory and immunomodulating properties [Jl. J hn- munol, 2007,178 (3): 1748-1758.

共引文献10

同被引文献33

  • 1李亚蕊,刘小莉,王俊英,高吊清,王艳芬,李俊,杨蕊华.单纯性肥胖儿童血浆瘦素水平的变化及相关因素的探讨[J].中国儿童保健杂志,2004,12(4):307-309. 被引量:10
  • 2彭惠,毕玫荣,潘峰.瘦素抵抗与肥胖的研究[J].中国优生与遗传杂志,2007,15(9):1-2. 被引量:9
  • 3Lobstein T,Baur I.,Uauy R. For the IASO international obesi ty task force. Obeshy in children and young people= a crisis in public health[J]. Obes Rev,2004,5(1) :84 85.
  • 4deJonge,vanOsehGebers,WillemsenSP,eta1.儿童早期的生长、肥胖与心脏结构的相关性研究[J].Hypertension,2011,57(5):934-940.
  • 5Franco C, Koranyi J, 13randberg J, et al. The reduction in vis ceral fat mass in reponse to growth hormone is more marked in men than in oes*rogen deficient women[J]. Growth Horm 1GF Res, 2009, 19(2):112-120.
  • 6Pasarica M, ZaehwieSa .1, Dejonge I., et al. Effect of gowth hormone on body composition and visceral adiposity in middle aged men with visceral obesity[J]. J Clin Endocrinol Metab, 2007,92(11) :4265-4270.
  • 7Maimaiti M, Tanahashi Y, Mohri Z, et al. Development of a Bioassay System for Human Growth Hormone Determination with Close Correlation to Immunoassay[J]. J Clin Lahorat A nal,2012,26:328-335.
  • 8growt Y, h ho Shirono H, Arisaka (), et al. Biologically e caused by an anti nac [J] J Clin Invest,1997, 100:1159 -1165.
  • 9Popii V, Baumann G. Laboratory measurement of growth hor mone[J]. Clin Chim Acta,2004,350: 1-16.
  • 10Carel J, Lahlou N, Roger M,et al. Precocious puberty and staturalgrowth[J]. Human Reproduction Update, 2004,10: 135 -147.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部